APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease

Neurobiology of Aging

Volumn 17, Issue 4, 1996, Pages 541-547

  Trieb, K ^b   Ransmayr, G ^b   Sgonc, R ^b   Lassmann, H ^b   Grubeck Loebenstein, B ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b NONE

Author keywords

Aging; Alzheimer's disease; Anergy; Autoimmunity; Immune system; Lymphocyte; Amyloid precursor protein (APP)

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL;

EID: 0029830124     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00068-1     Document Type: Article

References (11)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (3rd ed. - revised). Washington, DC: The American Psychiatric Association; 1987.
2. Avrameas, S. Natural autoantibodies: Self-recognition and phsiological immunity. In: Shoenfeld, Y.; Isenberg, D., eds. London: CRC Press; 1993:1-29.
3. Bush, A.; Martins, R.; Rumble, A.; Moir, R.; Fuller, S.; Milward, E.; Currie, J.; Ames, D.; Weidemann, A.; Fischer, P.; Multhaup, G.; Beyreuther, K.; Masters, C.. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 265:15977-15983; 1990.
4. Ciallella, J.; Rangnekar, V.; McGillis, J. Heat shock alters Alzheimer's ß amyloid precursor protein expression in human endothelial cells. J. Neurosci. Res. 37:769-776; 1994.
5. Citron, M.; Vigo-Pelfrey, C.; Teplow, D.; Miller, C.; Schenk, D.; Johnston, J.; Winblad, B.; Venizelos, W.; Lannfelt, L.; Selkoe, D. Excessive production of amyloid ß-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91:11993-11997; 1994.
6. Dighiero, G.; Lymberi, P.; Guilbert, B.; Ternynck, T.; Avrameas, S. Natural antibodies constitute a substantial part of normal circulating immunoglobulins. Ann. NY Acad. Sci. 475:135-145; 1986.
7. Estus, S.; Golde, T.; Kunishita, T.; Blades, D.; Lowery, D.; Eisen, M.; Usiak, M.; Qu, X.; Tabira, T.; Greenberg, B.; Younkin, S. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255:726-728; 1992.
8. Foldstein, M.; Foldstein, S.; McHugh, P. "Mini Mental State": A practical method for grading the cognitive state of patients for the clinican. J. Psychiatr. Res. 12:189-198; 1975.
9. Forsdyke, D. Two signal model of self/non-self immune discrimination: An update. J. Theoret. Biol. 154:109-118; 1992.
10. Gaskin, F.; Finley, J.; Fang, Q.; Xu, S.; Fu, S. Human antibodies reactive with ß-amyloid protein in Alzheimer's disease. J. Exp. Med. 177:1181-1186; 1993.
11. Glenner, G.; Wong, C. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid febril protein. Biochem. Biophys. Res. Commun. 122:1131-1135; 1984.